Published in J Med Chem on February 01, 1975
N-Hydroxyimide Ugi Reaction toward α-Hydrazino Amides. Org Lett (2017) 0.75
COMT inhibition with tolcapone does not affect carbidopa pharmacokinetics in parkinsonian patients in levodopa/carbidopa (Sinemet). Br J Clin Pharmacol (1999) 0.75
Duplication of the 15q11-13 region in a patient with autism, epilepsy and ataxia. Dev Med Child Neurol (1994) 1.63
Physiological disposition and metabolism of timolol in man and laboratory animals. Drug Metab Dispos (1976) 1.14
A peripherally acting alpha-2 adrenoceptor antagonist: L-659,066. J Pharmacol Exp Ther (1988) 1.11
Hypotensive ischemic optic neuropathy and peritoneal dialysis. Am J Ophthalmol (1999) 1.09
Therapeutic pancreatic endoscopy after Whipple resection requires rendezvous access. Endoscopy (2009) 1.07
Aphakic retinal detachment. Br J Ophthalmol (1985) 1.06
Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1975) 1.05
Studies on the absorption, excretion and metabolism of dimethylsulfoxide (DMSO) in man. J Pharmacol Exp Ther (1967) 1.01
The physiological disposition of lovastatin. Drug Metab Dispos (1989) 1.00
Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man. Drug Metab Dispos (1974) 0.99
Metabolism of a new hypolipidemic agent, 2-acetamidoethyl(p-chlorophenyl) (m-trifluoromethylphenoxy)-acetate (halofenate) in the rat, dog, rhesus monkey and man. J Pharmacol Exp Ther (1971) 0.99
The distinct effects of subchronic antipsychotic drug treatment on macronutrient selection, body weight, adiposity, and metabolism in female rats. Psychopharmacology (Berl) (2007) 0.95
Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica (1985) 0.95
Carcinoid tumor of the hepatic duct presenting as a Klatskin tumor in an adolescent and review of world literature. Hepatogastroenterology (2000) 0.90
Metabolism of dimethyl sulphoxide to dimethyl sulphone in the rat and man. Nature (1966) 0.88
Plasma levels of a new pelletized form of amitriptyline for maintenance therapy. J Clin Pharmacol (1975) 0.87
Phenylacetone oxime--an intermediate in the oxidative deamination of amphetamine. Biochem Pharmacol (1971) 0.86
Retinal detachment following Nd:YAG posterior capsulotomy. Eye (Lond) (1987) 0.86
The diagnosis and surgical management of acquired bilateral superior oblique palsy. Eye (Lond) (1987) 0.84
Molecular biology of circulatory shock. Part II. Expression of four groups of hepatic genes is enhanced after resuscitation from cardiogenic shock. Surgery (1990) 0.84
Comparative disposition of sulindac and metabolites in five species. Biochem Pharmacol (1978) 0.82
Absorption, distribution and metabolism of dimethylsulfoxide in the rat, rabbit and guinea pig. J Pharmacol Exp Ther (1966) 0.81
The effect of halofenate or halofenate free acid on human, rat and guinea pig platelet aggregation. Thromb Haemost (1976) 0.81
Metabolic disposition of simvastatin in patients with T-tube drainage. Drug Metab Dispos (1994) 0.81
Mesenteric vasoconstriction in cardiogenic shock in pigs. Gastroenterology (1992) 0.81
Effect of halofenate on binding of various drugs to human plasma proteins and on the plasma half-life of antipyrine in monkeys. J Pharm Sci (1972) 0.81
Disposition and metabolism of (+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d] cyclohepten-5,10-imine in rats, dogs, and monkeys. Drug Metab Dispos (1983) 0.81
Botulinum toxin therapy for squint. Eye (Lond) (1988) 0.81
Tinted contact lenses as an alternative management for photophobia in stationary cone dystrophies in children. J AAPOS (2006) 0.81
Physiological disposition of HMG-CoA-reductase inhibitors. Drug Metab Rev (1990) 0.80
Physiological disposition and metabolism of cyclobenzaprine in the rat, dog, rhesus monkey, and man. Drug Metab Dispos (1979) 0.79
Plasma levels and bioavailability of cyclobenzaprine in human subjects. J Clin Pharmacol (1978) 0.78
Evaluation of succinimidoethyl and pivaloyloxyethyl esters as progenitors of methyldopa in man, rhesus monkey, dog, and rat. Drug Metab Dispos (1979) 0.78
Contamination of disposable tonometer prisms during tonometry. Eye (Lond) (2006) 0.78
Isolated foveal retinoschisis as a cause of visual loss in young females. Br J Ophthalmol (2003) 0.78
Species differences in drug metabolism. Annu Rev Pharmacol (1970) 0.78
Single-dose pharmacokinetics of 14C-lovastatin in chronic renal failure. Clin Pharmacol Ther (1991) 0.77
GLC determination of cyclobenzaprine in plasma and urine. J Pharm Sci (1976) 0.77
Determination of cyproheptadine in plasma and urine by GLC with a nitrogen-sensitive detector. J Pharm Sci (1983) 0.76
Fetal surveillance in pregnancy complicated by diabetes mellitus: is it necessary? J Matern Fetal Neonatal Med (2002) 0.76
Single-dose pharmacokinetics and bioavailability of famotidine in man. Results of multicenter collaborative studies. Biopharm Drug Dispos (1988) 0.76
Improved reduction in pain in chronic pancreatitis with combined intraoperative celiac axis plexus block and lateral pancreaticojejunostomy. Curr Surg (2001) 0.75
Candida endophthalmitis presenting as bilateral posterior uveitis. J R Soc Med (1983) 0.75
A new method for assay of radioactive dimethyl sulfoxide and its metabolite, dimethyl sulfone. Experientia (1966) 0.75
Synthesis and evaluation of esters of N,N-bis(2-chloroethyl)-p-aminophenol and N,N-bis(2-bromoethyl)-p-aminophenol as potential antitumor agents. J Med Chem (1969) 0.75
Developing software in the Third World: Papua New Guinea provincial health information system. J Trop Pediatr (1993) 0.75
The metabolic disposition of (S)-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in rats, dogs, and humans. Drug Metab Dispos (1980) 0.75
Physiologic disposition and metabolism of an anti-ulcer agent, N-(2-diisopropylaminoethyl)-N-(4,6-dimethyl-2-pyridyl)-N',N'-dimethylurea, in rats, dogs, and monkeys. Drug Metab Dispos (1982) 0.75
Metabolism of methyldopa in man after oral administration of the pivaloyloxyethyl ester. Drug Metab Dispos (1984) 0.75
Rapid, sensitive gas-liquid chromatographic method for determination of amitryptyline and nortriptyline in plasma using a nitrogen-sensitive detector. J Chromatogr (1977) 0.75
Metabolism of protriptyline by rabbit liver in vitro. Pharmacology (1979) 0.75
Bioavailability of indomethacin in man. Ann Clin Res (1974) 0.75
Determination of various drugs in rodent diet mixtures. J Chromatogr (1977) 0.75
The disposition and metabolism of an orexigenic agent, 10,11-dihydro-5-(1-methyl-4-piperidinylidene)-5H-dibenzo[a,d]cyclohepten-3-carboxylic acid, in the rat, dog, and cat. Drug Metab Dispos (1982) 0.75
GLC method for quantitative determination of amitriptyline in human plasma. J Pharm Sci (1974) 0.75
GLC analysis of lidocaine in plasma using a novel nitrogen-sensitive detector. J Pharm Sci (1976) 0.75
Metabolism of the platelet-activating factor antagonist (+/-)-trans-2-(3'-methoxy-5'-methylsulphonyl-4'-propoxyphenyl)-5-(3",4" ,5"- trimethoxyphenyl)tetrahydrofuran (L-659,989) in rhesus monkeys. Xenobiotica (1991) 0.75
Metabolism of the TRH analog L-pyro-2-aminoadipyl-L-histidyl-[3H]-L-thiazolidine-4-carboxamide (MK-771) in gut and brain tissue of rats: the implications for its bioavailability. Drug Metab Dispos (1983) 0.75
Physiologic disposition and metabolic fate of indomethacin analogs. I. 1-p-chlorobenzylidenyl-5-methoxy-2-methylindene-3-acetic acid. J Pharm Sci (1971) 0.75
A technique for the improvement of gas chromatographic properties of tertiary amines such as amitriptyline. J Chromatogr (1968) 0.75
Metabolism of a pharmacologically active pyrrolidine derivative (prolintane) by lactam formation. Experientia (1972) 0.75
Gas-liquid chromatographic determination of nanogram amounts of cyclobenzaprine in plasma using a nitrogen detector. J Chromatogr (1976) 0.75
Physiologic disposition and metabolic fate of indomethacin analogs. II. 1-(p-chlorobenzoyl)-5-dimethylamino-2-methylindole-3-acetic acid. J Pharm Sci (1971) 0.75
Metabolism of kadsurenone and 9,10-dihydrokadsurenone in rhesus monkeys and rat liver microsomes. Drug Metab Dispos (1989) 0.75
Simple, sensitive spectrophotofluorometric method for hydrazine in plasma. Anal Chem (1974) 0.75
Physiological disposition and urinary metabolites of cyproheptadine in the dog, rat, and cat. Drug Metab Dispos (1975) 0.75
Potential folic acid antagonists. I. The antitumor and folic acid reductase inhibitory properties of 6-substituted 2,4-diamino-5-arylazopyrimidines. J Med Chem (1965) 0.75
Light-near dissociation of pupil reactions as a presenting feature of von Hippel-Lindau disease. Eye (Lond) (2005) 0.75
Epoxide metabolites of protriptyline in rat urine. Drug Metab Dispos (1975) 0.75
Metabolism of cyclobenzaprine in the dog. Drug Metab Dispos (1978) 0.75
Spectrofluorometric determination of carbidopa (L-(-)-alpha-hydrazino-3, 4-dihydroxy-alpha-methylhydrocinnamic acid) in plasma. J Pharm Sci (1973) 0.75
Bioavailability assessment under quasi- and nonsteady-state conditions III: Application. J Pharm Sci (1976) 0.75
GLC determination of (-)-1-cyclopropylmethyl-4-(3-trifluoromethylthio-5H-dibenzo [a,d]cyclohepten-5-ylidene)piperidine in human plasma and urine. J Pharm Sci (1983) 0.75
GLC determination of S-2-(3-tert-butylamino-2-hydroxypropoxy)-3-cyanopyridine in human plasma. J Pharm Sci (1979) 0.75
Sensitive high-performance liquid chromatographic assay using electrochemical detection for a novel prodrug ester of methyldopa, pivaloyloxyethyl 3-(3,4-dihydroxyphenyl)-2-methylalaninate, in plasma and urine. J Chromatogr (1984) 0.75
Urinary metabolites of amitriptyline in the dog. Drug Metab Dispos (1977) 0.75
Intermediates in drug metabolism reactions. Drug Metab Rev (1973) 0.75
Phenylacetone oxime--an intermediate in amphetamine deamination. Drug Metab Dispos (1974) 0.75
Use of gender and oxygenation as synonyms for sex and oxidation. Drug Metab Dispos (1995) 0.75